Zoster-associated neuralgias;Zosterneuralgien

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 10, 2006, Pages 871-881

  Wassilew, Sawko W ^a,b  

^a Dermatology Clinic   (Germany)

^b Dermatol Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; CAPSAICIN; CARBAMAZEPINE; CORTICOSTEROID; DIHYDROCODEINE; DIPYRONE; FAMCICLOVIR; GABAPENTIN; LIDOCAINE; LOCAL ANESTHETIC AGENT; METOCLOPRAMIDE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; PARACETAMOL; PHENYTOIN; PREDNISOLONE; PREDNISONE; PREGABALIN; TILIDINE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VALACICLOVIR;

ALLODYNIA; BLURRED VISION; BURNING SENSATION; CLINICAL TRIAL; CONSTIPATION; DIZZINESS; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; GANGLION; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HUMAN; INCIDENCE; INCREASED APPETITE; INFLAMMATION; MEMORY DISORDER; NAUSEA; NERVE BLOCK; NEUROPATHIC PAIN; ONSET AGE; OPIATE ADDICTION; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PERIPHERAL NERVE; POSTHERPETIC NEURALGIA; REVIEW; RISK FACTOR; SENSORY DYSFUNCTION; SKIN DEFECT; TREATMENT CONTRAINDICATION; URINE RETENTION; VIRUS REPLICATION; XEROSTOMIA;

HERPES ZOSTER; HUMANS; NEURALGIA; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; SKIN DISEASES, VIRAL;

EID: 33748920908     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.06009.x     Document Type: Review

References (43)

1. Alper BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? Fam. Pract. 2000; 49: 255-264.
2. Arvin A. Aging, Immunity, and the Varicella-Zoster Virus. N. Engl. J. Med. 2005; 352: 2266-2267.
3. Baron R, Jänig W. Neuropathische Schmerzen. In: Zenz M, Jurna I, Hrsg. Lehrbuch der Schmerztherapie 2001, Wiss. Verl.-Ges. Stuttgart; 65-87.
4. Baron R. Medikamentöse Therapie bei neuropathischen Schmerzen. In: Zenz M, Jurna I, Hrsg. Lehrbuch der Schmerztherapie 2001, Wiss. Verl.-Ges. Stuttgart; 475-484.
5. Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. Pain 1997; 13: 327-331.
6. Bowsher D. Factors influencing the features of postherpetic neuralgia and outcome when treated with tricyclies. Eur. J. Pain 2003; 7: 1-7.
7. Brisson M, Edmunds WJ. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J. Med. Virol. 2003; 70: 31-37.
8. Choo PW, Galil K, Donahue JG, Walker AM, Spiegelman D, Platt R. Risk factors for postherpetic neuralgia. Arch. Intern. Med. 1997; 157: 1217-1224.
9. DGN (Deutsche Gesellschaft für Neurologie). Leitlinien 2002. www.dgn.org.
10. Dworkin RH, Carrington D, Cunningham A, Kost RG, Levin MJ, McKendrick MW, Oxman MN, Rentier B, Schmader KE, Tappeiner G, Wassilew SW, Whitley RJ. Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antivir. Res. 1997; 33: 73-85.
11. Dworkin RH, Perkins FM, Nagasako EM. Prospects for the prevention of postherpetic neuralgia in herpes zoster patients. Clin. J. Pain 2000; 16: 90-100.
12. Dworkin RH, Corbin AE, Young Jr. JP, Sharma U, LaMoreaux L, Bockbrader H, Garofalo EA, Poole RM . Pregabalin for the treatment of postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology 2003; 60: 1274-1283.
13. Gilron I, Bailey JM, Dongsheng T, Holden RR, Weaver DF, Houlden RL. Morphine, Gabapentin, or their combination for neuropathic pain. N. Engl. J. Med. 2005; 352: 1324-1334.
14. Gross G, Schöfer H, Wassilew SW, Friese K, Timm A, Guthoff R, Pau HW, Malin JP, Wutzler P, Doerr HW. Herpes zoster guideline of the German Dermatology Society (DDG). J. Clin. Virol. 2003; 26: 277-289.
15. Harke H, Gretenkort P, Ladleif HU, Koester P, Rahman S. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth. Analg. 2004; 94: 694-700.
16. Hwang SM, Kang YC, Lee YB, Yoon KB, Ahn SK, Choi EH. The effects of epidural blockade on the acute pain in herpes zoster. Arch. Dermatol. 1999; 133: 1359-1364.
17. Johnson RW, Whitton TL. Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opin. Pharmacother. 2004; 5: 551-559.
18. Jung BF, Johnson RW, Griffin DRJ, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62: 1545-1551.
19. McKendrick MW, Care CC, Kudesia G, Bates CJ, Oxley MK, Eley A. Is VZV reactivation a common cause of unexplained unilateral pain? Results of a prospectic study of 57 patients. J. Infec. 1999; 39: 209-212.
20. Kotani N, Kudo R, Sakurai Y, Sawamura D, Sessler DI, Okada H, Nakayama H, Yamagata T, Yasujima M, Matsuki A. Cerebrospinal fluid interleukin 8 concentrations and the subsequent development of postherpetic neuralgia. Am. J. Med. 2004; 116: 318-324.
21. Kumar V, Krone K, Mathieu A. Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia: an appraisal of current evidence. Reg. Anesth. Pain. Med. 2004; 29: 454-461.
22. Lilie HM, Wassilew SW. The role of antivirals in the management of neuropathic pain in the older patient with herpes zoster. Drugs Aging 2003; 20: 561-570.
23. Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam. Pract. 2002; 19: 471-475.
24. Opstelten W, van Wijck AJM, Stolker RJ. Interventions to prevent postherpetic neuralgia: cutaneous and percutaneous techniques. Pain 2004; 107: 202-206.
25. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Hongyuan Zhang J, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann Jr, JW, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh S-S, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan ISF, Wang WWB, Annunziato PW, and Silber JL, for the Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults N Engl J Med 2005; 352: 2271-2284.
26. Pasqualucci A, Pasqualucci V, Galla F, De Angelis V, Marzocchi R, Colussi F, Paoletti M, Girardis M, Lugano, Del Sindaco F. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta. Anaesthesiol. Scand. 2000; 44: 910-918.
27. Plaghki L, Adriaensen H, Morlion B, Lossignol D, Devulder J. Systematic overview of the pharmacological management of postherpetic neuralgia. Dermatology 2004; 208: 206-216.
28. Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, Royll RM, Max MB. Opioids versus antidepressants in post-herpetic neuralgia. A randomized, placebo-controlled trial. Neurology 2002; 59: 1015-1021.
29. Rowbotham MC, Baron R, Petersen KL, Fields HL. Spectrum of pain mechanisms contributing to PHN. In: Watson CPN, Gershon AA, ed. Herpes zoster and postherpetic neuralgia. Amsterdam: Elsevier 2001; 183-195.
30. Santee JA. Corticosteroids for herpes zoster: what do they accomplish? Am. J. Clin. Dermatol. 2002; 3: 517-524.
31. Sato-Takeda M, Ihn H, Ohashi J, Tsuchiya N, Satake M, Arita H, Tamaki K, Hanaoka K, Tokunaga K, Yabe T. The human histocompatibility leukocyte antigen (HLA) haplotype is associated with the onset of postherpetic neuralgia after herpes zoster. Pain 2004; 110: 329-336.
32. Schäfer M. Efficacy of peripheral opioid analgesia in inflammatory pain: evidence from clinical studies. In: Kalso E., McQuay HJ, Wiesenfeld-Hallin Z, eds. Opioid sensitivity of chronic non-cancer pain: Seattle: IASP Press 1999; 327-336.
33. Sorkin LS, Xiao WH, Wagner R, Myers RR. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 1997; 81: 255-262.
34. Wassilew SW, Wutzler P, on behalf of the Brivudin Herpes Zoster Study Group. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study. Antivir. Res. 2003; 59: 49-56.
35. Wassilew SW, Wutzler P, on behalf of the Brivudin Herpes Zoster Study Group. Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia. Antivir. Res. 2003; 59: 57-60.
36. Wassilew SW, on behalf of Collaborative Brivudin PHN Study Group. Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study. JEADV 2005; 19: 47-55.
37. Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998; 50: 1837-1841.
38. Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG, Schleupner CJ, Hayden F, Wolf J, Seng-jaw S, and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placobo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann. Intern. Med. 1996; 125: 376-383.
39. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks JA. Randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N. Engl. J. Med. 1994; 330: 896-900.
40. Wu CL, Marsh A, Dworkin RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain 2000; 87: 121-129.
41. Wulf H, Schattschneider J, Baron R. Zoster und postzosterische Neuralgie. In: Zenz M, Jurna I, Hrsg. Lehrbuch der Schmerztherapie 2001, Wiss. Verl.-Ges. Stuttgart; 757-768.
42. Wutzler P, Meister W. Herpes zoster - Symptomatologie, demographische Daten und prognostische Faktoren. Dt. Ärzteblatt 1997; 94: 900-904.
43. Zaal MJW, Völker-Dieben HJ, D' Amaro J. Risk and prognostic factors of postherpetic neuralgia and focal sensory denervation: a prospective evaluation in acute herpes zoster ophthalmicus. Clin. J. Pain 2000; 16: 345-351.